Policy and Legislation
AHA report results are expected to assist policymakers in understanding the impact of the funds on financial performance.
The rule will standardize certain operations across the marketplaces with an eye toward increasing reliability and consistency, says HHS.
Total gross Medicare spending on GLP-1 drugs has skyrocketed, rising from $57 million in 2018 to $5.7 billion in 2022.
The draft outlines federal health IT goals that are focused on improving access to health data.
If finalized, total payments are estimated to increase by $70 million in 2025.
This is despite payment errors under Medicaid dropping by $30 billion from the previous year.
The rule limits short-term plans to no more than four months instead of the current three years as set under the Trump administration.
HIMSS24
AI, technology to improve maternal health outcomes and funding for public health data modernization are big topics at HIMSS24, says Tom Leary, SVP and head of government relations at HIMSS.
Upwards of 41 drugs available through Medicare Part B could have a lowered Part B coinsurance rate from April 1 to June 30.
A decision is expected this summer during the 2024 presidential campaign.